問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Hospital

Division of Obstetrics & Gynecology

更新時間:2025-08-20

周振陽醫師
  • Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

3Cases

2020-12-01 - 2024-01-30

Phase II

Completed
Phase 2 Study Investigating Efficacy and Safety of Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody BGB-A1217 in Patients With Previously Treated Recurrent or Metastatic Cervical Cancer
  • Condition/Disease

    Recurrent or Metastatic Cervical Cancer

  • Test Drug

    BGB-A317 、BGB-A1217

Participate Sites
6Sites

Recruiting6Sites

2011-06-01 - 2018-02-28

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2025-03-01 - 2030-03-31

Phase III

Active
A Phase III, Randomized, Multi-site, Open-label Trial of BNT323/DB-1303 Versus Investigator's Choice of Chemotherapy in Previously Treated Patients With HER2- Expressing Recurrent Endometrial Cancer
  • Condition/Disease

    Endometrial Cancer

  • Test Drug

    溶液用粉劑

Participate Sites
6Sites

Recruiting6Sites